Differentiation of PTH-Expressing Cells From Human Pluripotent Stem Cells.


Journal

Endocrinology
ISSN: 1945-7170
Titre abrégé: Endocrinology
Pays: United States
ID NLM: 0375040

Informations de publication

Date de publication:
01 10 2020
Historique:
received: 09 05 2020
accepted: 07 08 2020
pubmed: 19 8 2020
medline: 2 2 2021
entrez: 19 8 2020
Statut: ppublish

Résumé

Differentiation of pluripotent stem cells into functional parathyroid-like cells would accelerate development of important therapeutic options for subjects with parathyroid-related disorders, from the design and screening of novel pharmaceutical agents to the development of durable cellular therapies. We have established a highly reproducible directed differentiation approach leading to PTH-expressing cells from human embryonic stem cells and induced pluripotent stem cells. We accomplished this through the comparison of multiple different basal media, the inclusion of the CDK inhibitor PD0332991 in both definitive endoderm and anterior foregut endoderm stages, and a 2-stage pharyngeal endoderm series. This is the first protocol to reproducibly establish PTH-expressing cells from human pluripotent stem cells and represents a first step toward the development of functional parathyroid cells with broad applicability for medicinal and scientific investigation.

Identifiants

pubmed: 32810225
pii: 5893997
doi: 10.1210/endocr/bqaa141
pmc: PMC7505176
pii:
doi:

Substances chimiques

PTH protein, human 0
Parathyroid Hormone 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NCI NIH HHS
ID : R21 CA240660
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States

Informations de copyright

© Endocrine Society 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Références

Nat Biotechnol. 2006 Nov;24(11):1392-401
pubmed: 17053790
Curr Opin Genet Dev. 2010 Aug;20(4):420-7
pubmed: 20566281
Stem Cells Dev. 2010 Nov;19(11):1735-43
pubmed: 20230268
Stem Cells Dev. 2009 Sep;18(7):1071-80
pubmed: 19025488
PLoS Genet. 2019 Feb 14;15(2):e1007996
pubmed: 30763319
Dev Biol. 2012 Jan 15;361(2):208-19
pubmed: 22057081
Endocrinol Metab Clin North Am. 2018 Dec;47(4):771-782
pubmed: 30390812
Surgery. 2005 Dec;138(6):1033-40; discussion 1040-1
pubmed: 16360388
Nat Cell Biol. 2014 Dec;16(12):1146-56
pubmed: 25419850
Stem Cell Reports. 2013 Oct 31;1(5):464-78
pubmed: 24286033
Annu Rev Cell Dev Biol. 2009;25:221-51
pubmed: 19575677
Physiol Genomics. 2015 Jun;47(6):232-9
pubmed: 25852171
Stem Cells. 2011 Sep;29(9):1469-74
pubmed: 21714037
Mech Dev. 2001 May;103(1-2):141-3
pubmed: 11335122
Nature. 2019 May;569(7756):361-367
pubmed: 30959515
Gene Expr Patterns. 2006 Oct;6(8):794-9
pubmed: 16517216
Front Physiol. 2016 Oct 25;7:488
pubmed: 27826253
Development. 2000 Jul;127(14):3079-90
pubmed: 10862745
Front Physiol. 2016 Dec 15;7:563
pubmed: 28018229
Stem Cell Reports. 2016 Jul 12;7(1):19-28
pubmed: 27411102
Stem Cell Rev Rep. 2013 Oct;9(5):578-85
pubmed: 23719997
Surgery. 2010 Dec;148(6):1186-9; discussion 1189-90
pubmed: 21134550
Int J Dev Biol. 2002;46(4):415-22
pubmed: 12141427
Nat Protoc. 2015 Mar;10(3):413-25
pubmed: 25654758
Stem Cell Res. 2016 Mar;16(2):338-41
pubmed: 27345999
Genes Dev. 1996 Jan 1;10(1):60-9
pubmed: 8557195
Lancet Diabetes Endocrinol. 2013 Dec;1(4):275-83
pubmed: 24622413
Mod Pathol. 2011 Apr;24 Suppl 2:S78-93
pubmed: 21455204
Curr Opin Nephrol Hypertens. 2007 Jul;16(4):305-10
pubmed: 17565271
Nat Biotechnol. 2014 Jan;32(1):84-91
pubmed: 24291815
Nat Rev Immunol. 2004 Apr;4(4):278-89
pubmed: 15057786
Eur J Clin Invest. 1990 Aug;20(4):392-7
pubmed: 2121498
Eur Arch Otorhinolaryngol. 2016 Apr;273(4):827-35
pubmed: 25567344
J Clin Endocrinol Metab. 2019 Nov 1;104(11):5136-5147
pubmed: 31369089
Cell. 2013 Sep 26;155(1):135-47
pubmed: 24074866
Endocr Rev. 2019 Apr 1;40(2):631-668
pubmed: 30541144
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609

Auteurs

Betty R Lawton (BR)

Department of Laboratory Medicine, Yale Stem Cell Center, Yale University, New Haven, Connecticut.

Corine Martineau (C)

Center for Bone Health and Division of Endocrinology and Diabetes, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.

Julie Ann Sosa (JA)

Department of Surgery, University of California San Francisco, San Francisco, California.

Sanziana Roman (S)

Department of Surgery, University of California San Francisco, San Francisco, California.

Courtney E Gibson (CE)

Department of Surgery, Yale University, New Haven, Connecticut.

Michael A Levine (MA)

Center for Bone Health and Division of Endocrinology and Diabetes, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.

Diane S Krause (DS)

Department of Laboratory Medicine, Cell Biology, Yale Stem Cell Center, Yale University, New Haven, Connecticut.
Department of Pathology, Yale Stem Cell Center, Yale University, New Haven, Connecticut.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH